BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines share Options Outstanding — Weighted-Average Exercise Price ($/sh) ($)
Form 10-K Share-Based Compensation Note (XBRL)
Latest, FY2025
12.46
Period ended Dec 31, 2025
Change on a year earlier
+28.5%
9.70 in FY2024
History
8 years
Since FY2018
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Share Options Outstanding — Weighted-Average Exercise Price ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.46 | +28.5% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 9.70 | +7.1% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 9.06 | +15.4% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 7.85 | +10.9% | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 7.08 | +34.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 5.27 | +33.1% | Form 10-K (filed 2024-02-26) ↗ |
| FY2019 | Dec 31, 2019 | 3.96 | +23.4% | Form 10-K (filed 2023-02-27) ↗ |
| FY2018 | Dec 31, 2018 | 3.21 | – | Form 10-K (filed 2022-02-28) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Share Options Outstanding — Weighted-Average Exercise Price ($/sh) ($), annual FY2018–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/opt_out_waep
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.